MedTrace Logo

The Stockholm CREAtinine Measurements Project

NCT06239129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3200000

Last updated 2024-02-02

No results posted yet for this study

Summary

The Stockholm CREAtinine Measurements (SCREAM) project is a healthcare utilization cohort including, at present, all adult residents in Stockholm between 2006 and 2021. The region of Stockholm had a population of 2.3 million citizens in 2021and provides universal healthcare with a single unified health-system. Administrative databases with complete information on socidemographic data, healthcare use, diagnoses and therapeutic/surgical procedures, and vital status were enriched with performed laboratory tests, dispensed prescriptions at Swedish pharmacies and validated kidney replacement therapy endpoints. Registries were linked and de-identified by the Swedish National Board of Welfare and are considered to have no or minimal loss to follow-up. Because the study utilized de-identified data, it was deemed not to require informed consent and was approved by the regional ethical review boards and the Swedish National Board of Welfare.

For detailed description of available data and linked registers please consult:

https://pubmed.ncbi.nlm.nih.gov/35028991/

Conditions

Interventions

DRUG

Initiation of specific medications

multiple therapies studied within this database

PROCEDURE

Undertaking of specific procedures

multiple procedures/surgeries studied within this database

DIAGNOSTIC_TEST

Abnormalities in specific laboratory tests

multiple abnormalities in laboratory values (i.e. CRP, cholesterol, eGFR, potassium) studied within this database

Sponsors & Collaborators

Principal Investigators

  • Juan J Carrero, Prof · Karolinska Institutet

Eligibility

Min Age
0 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-01
Primary Completion
2021-12-31
Completion
2022-12-31
FDA Drug
Yes

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06239129 on ClinicalTrials.gov